ELAVL1 and pancreatic neoplasm: In addition, HuR can bind to PARG mRNA under the stimulation of PARP inhibitors, and the inhibition of HuR binding to PARG mRNA helps to improve PARP inhibition therapy in pancreatic cancer cells [82].